Photocure Announces the Commercial Availability of Karl Storz’s New Blue Light System in the U.S.
Karl Storz and Photocure to collaborate on commercializing the high-definition system Press Release – Oslo, Norway, September 28, 2022: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the commercial availability of Karl Storz’s New Blue Light equipment powered by Saphira™ in the U.S. As part of the rollout, Karl Storz plans to host a Virtual Launch event for the medical community streamed from its El Segundo, California office where Sia Daneshmand M.D. and Kristin Scarpato M.D. M.P.H. will discuss the clinical benefits of using BLC[®] with Cysview[® ]for NBMIC*, while